Results for tag: "Combination Inhaler"

The Combination Inhaler market is a subset of the Inhaler and Nebuliser market. Combination Inhalers are devices that deliver two or more medications in a single inhalation. These devices are used to treat a variety of respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Combination Inhalers are designed to provide a more effective and convenient treatment option than traditional inhalers and nebulisers. Combination Inhalers are typically composed of a pressurised metered-dose inhaler (pMDI) and a dry powder inhaler (DPI). The pMDI delivers a combination of medications in a single aerosolised dose, while the DPI delivers a combination of medications in a dry powder form. The combination of medications in a single inhalation allows for more effective and efficient delivery of the medications. The Combination Inhaler market is highly competitive, with a number of companies offering a variety of devices. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, and Merck. Show Less Read more